InSysBio News

September 2025

10 1. 10 Sep 2025 15:18 InSysBio to participate in ACoP 2025 InSysBio announces its participation in 2025 American Conference on Pharmacometrics (ACoP 2025) which is to be held from October 18-21, 2025 at the Gaylord Rockies, Aurora, Colorado, USA. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #11 and 2 posters in frames of the Conference

25 1. 25 Sep 2025 14:12 InSysBio to take part in BioTechX Europe 2025 InSysBio announces its participation in BioTechX Europe 2025 on 6–8 October 2025 at Messe Basel, Switzerland. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, is going to present InSysBio's modeling services for drug research & development at the Booth S62

30 1. 30 Sep 2025 16:17 InSysBio to participate in JuliaCon Local Paris 2025 InSysBio announces its participation in JuliaCon Local Paris 2025 which is to be held from October 2-3, 2025 at the National Conservatory of Arts and Crafts, Paris, France. Ivan Borisov, Senior Software Developer at InSysBio, will present a poster in frames of the Conference

NEWS

Software

February 2, 2017

ISBM releases the updated version of Immune Response Template

Moscow, Russia - February 2, 2017. Institute for Systems Biology Moscow (ISBM) announced the recent update of the Immune Response Template (IRT) platform and its online demo. The project aimed to integrate and visualize available data on immune cells, cytokine, chemokines and other mediators interactions in human. IRT is a unique tool due to its focus on quantitative systems pharmacology (QSP) modeling. Using the platform modelers in pharmaceutical companies can strongly improve the drug R&D process.

LEARN MORE

NEWS

Conference

December 21, 2016

Big data and decision support systems for pharmaceuticals

Moscow, Russia - December 20, 2016. Oleg Demin, CEO of the Institute for Systems Biology Moscow, gave a talk at the seminar "Big data and decision support systems for pharmaceuticals.".

LEARN MORE

NEWS

Publication

November 28, 2016

A New Mathematical Model of the Eosinophil Lifecycle Shows Irrelevance of the Asthma Biomarker Choice

Moscow, Russia - November 29th, 2016. Institute for Systems Biology Moscow (www.insysbio.ru), one of the pioneers in bio-modeling and simulation announced the study made in collaboration with scientists of two pharmaceutical leaders: MedImmune and AstraZeneca.

LEARN MORE